HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Attenuated Infections

Attenuated Infections

Beyond viral vaccines, attenuated bacterial infections have garnered attention for their potential therapeutic applications. Attenuation in bacteria involves weakening their virulence while maintaining essential features for triggering an immune response. This approach has been explored in the development of live attenuated bacterial vaccines against pathogens like Mycobacterium tuberculosis. Attenuated strains can serve as carriers for vaccine antigens, delivering them to the immune system while eliciting protective immune responses. Attenuated bacteria also hold promise in cancer therapy. Engineered bacteria, such as Salmonella or Escherichia coli, can be used as delivery vehicles for therapeutic agents, including anticancer drugs or immunomodulators. These bacteria preferentially accumulate in tumors due to their unique microenvironment, providing a targeted and localized treatment approach. Researchers are actively investigating the safety, efficacy, and potential side effects of such attenuated bacterial therapies. The development and application of attenuated bacterial strains require a comprehensive understanding of bacterial pathogenesis, host responses, and the intricacies of the targeted disease. Balancing attenuation to ensure safety while preserving immunogenicity remains a critical challenge in these endeavors. Ongoing research aims to optimize these approaches for a range of therapeutic purposes, opening new avenues in the fields of infectious diseases and cancer therapeutics.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp